A Phase 3 Comparative Study of TAP-144-SR(6M) in Postoperative and Hormone Therapy-naïve Patients With Premenopausal Breast Cancer
NCT01546649
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
167
Enrollment
INDUSTRY
Sponsor class
Conditions
Premenopausal Breast Cancer
Interventions
DRUG:
TAP-144-SR(6M)
DRUG:
TAP-144-SR(3M)
Sponsor
Takeda